These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38791816)

  • 41. COVID-19 Related Medical Mistrust, Health Impacts, and Potential Vaccine Hesitancy Among Black Americans Living With HIV.
    Bogart LM; Ojikutu BO; Tyagi K; Klein DJ; Mutchler MG; Dong L; Lawrence SJ; Thomas DR; Kellman S
    J Acquir Immune Defic Syndr; 2021 Feb; 86(2):200-207. PubMed ID: 33196555
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HIV care engagement and ART adherence among Kenyan gay, bisexual, and other men who have sex with men: a multi-level model informed by qualitative research.
    Graham SM; Micheni M; Secor A; van der Elst EM; Kombo B; Operario D; Amico KR; Sanders EJ; Simoni JM
    AIDS Care; 2018 Aug; 30(sup5):S97-S105. PubMed ID: 30668136
    [TBL] [Abstract][Full Text] [Related]  

  • 43. To switch or not to switch: Intentions to switch to injectable PrEP among gay and bisexual men with at least twelve months oral PrEP experience.
    Meyers K; Wu Y; Brill A; Sandfort T; Golub SA
    PLoS One; 2018; 13(7):e0200296. PubMed ID: 30024903
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Motivations for opioid and stimulant use among drug using black sexual minority men: A life course perspective.
    Dangerfield Ii DT; Heidari O; Cooper J; Allen S; Lucas GM
    Drug Alcohol Depend; 2020 Oct; 215():108224. PubMed ID: 32777690
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Awareness of and willingness to use pre-exposure prophylaxis (PrEP) among people who inject drugs and men who have sex with men in India: Results from a multi-city cross-sectional survey.
    Belludi A; McFall AM; Solomon SS; Celentano DD; Mehta SH; Srikrishnan AK; Kumar MS; Solomon S; Lucas GM
    PLoS One; 2021; 16(2):e0247352. PubMed ID: 33630909
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identifying social and economic barriers to regular care and treatment for Black men who have sex with men and women (BMSMW) and who are living with HIV: a qualitative study from the Bruthas cohort.
    Arnold EA; Weeks J; Benjamin M; Stewart WR; Pollack LM; Kegeles SM; Operario D
    BMC Health Serv Res; 2017 Jan; 17(1):90. PubMed ID: 28129757
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exploring preferences and decision-making about long-acting injectable HIV pre-exposure prophylaxis (PrEP) among young sexual minority men 17-24 years old.
    John SA; Zapata JP; Dang M; Pleuhs B; O'Neil A; Hirshfield S; Walsh JL; Petroll AE; Quinn KG
    Sci Rep; 2023 Mar; 13(1):5116. PubMed ID: 36991027
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patient and Physician Preferences Regarding Long-Acting Pre-Exposure Prophylaxis and Antiretroviral Therapy: A Mixed-Methods Study in Southern California, USA.
    Yeager S; Montoya JL; Burke L; Chow K; Moore DJ; Morris S
    AIDS Res Hum Retroviruses; 2022 Nov; 38(11):856-862. PubMed ID: 35972754
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of Determinants and Implementation Strategies to Increase Long-Acting Injectable PrEP for HIV Prevention Among Latino Men Who Have Sex with Men (MSM).
    Zapata JP; Zamantakis A; Queiroz AAFLN
    J Racial Ethn Health Disparities; 2024 Aug; 11(4):2093-2102. PubMed ID: 37347407
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patient Education and Decision Support for Long-Acting Injectable HIV Antiretroviral Therapy: Protocol for Tool Development and Pilot Testing with Ryan White HIV/AIDS Program Medical Case Management Programs in New York.
    Irvine MK; Zimba R; Avoundjian T; Peterson M; Emmert C; Kulkarni SG; Philbin MM; Kelvin EA; Nash D
    JMIR Res Protoc; 2024 Mar; 13():e56892. PubMed ID: 38536227
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Scripted, PrEP-Using Peer Change Agent Improves Perceived Risk for HIV and Willingness to Accept Referrals Quickly Among Black Sexual Minority Men: Preliminary Findings from POSSIBLE.
    Dangerfield Ii DT; Anderson JN
    AIDS Behav; 2024 Jun; 28(6):2156-2165. PubMed ID: 38551719
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The LAIs Are Coming! Implementation Science Considerations for Long-Acting Injectable Antiretroviral Therapy in the United States: A Scoping Review.
    Kanazawa JT; Saberi P; Sauceda JA; Dubé K
    AIDS Res Hum Retroviruses; 2021 Feb; 37(2):75-88. PubMed ID: 33176429
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nursing and Health Care Preferences Among Opioid and Stimulant Using Black Sexual Minority Men: An Exploratory Study.
    Dangerfield DT; Cooper J; Heidari O; Allen S; Winder TJA; Lucas GM
    J Assoc Nurses AIDS Care; 2021 Sep-Oct 01; 32(5):e30-e39. PubMed ID: 32809988
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Race-based medical mistrust, medication beliefs and HIV treatment adherence: test of a mediation model in people living with HIV/AIDS.
    Kalichman SC; Eaton L; Kalichman MO; Grebler T; Merely C; Welles B
    J Behav Med; 2016 Dec; 39(6):1056-1064. PubMed ID: 27392477
    [TBL] [Abstract][Full Text] [Related]  

  • 55. "If I have nothing to eat, I get angry and push the pills bottle away from me": A qualitative study of patient determinants of adherence to antiretroviral therapy in the Democratic Republic of Congo.
    Musumari PM; Feldman MD; Techasrivichien T; Wouters E; Ono-Kihara M; Kihara M
    AIDS Care; 2013; 25(10):1271-7. PubMed ID: 23383757
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Willingness of community-recruited men who have sex with men in Washington, DC to use long-acting injectable HIV pre-exposure prophylaxis.
    Levy ME; Patrick R; Gamble J; Rawls A; Opoku J; Magnus M; Kharfen M; Greenberg AE; Kuo I
    PLoS One; 2017; 12(8):e0183521. PubMed ID: 28827821
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Willingness to use long-acting injectable PrEP among HIV-negative/unknown men who have sex with men in mainland China: A cross-sectional online survey.
    Fu J; Dai Z; Wang H; Si M; Chen X; Wu Y; Xiao W; Huang Y; Yu F; Mi G; Su X
    PLoS One; 2023; 18(10):e0293297. PubMed ID: 37856527
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Culturally Relevant Africultural Coping Moderates the Association Between Discrimination and Antiretroviral Adherence Among Sexual Minority Black Americans Living with HIV.
    Wagner GJ; Bogart LM; Klein DJ; Lawrence SJ; Goggin K; Gizaw M; Mutchler MG
    AIDS Behav; 2024 Feb; 28(2):408-420. PubMed ID: 38060112
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Black Sexual Minority Men's Stigma-Based Experiences Surrounding Pre-exposure Prophylaxis in the Southern United States.
    Hanna-Walker V; Simon KA; Lawrence SE; Driver R; Kalinowski J; Watson RJ; Eaton LA
    LGBT Health; 2023 Apr; 10(3):245-251. PubMed ID: 36516136
    [No Abstract]   [Full Text] [Related]  

  • 60. National trends in HIV pre-exposure prophylaxis awareness, willingness and use among United States men who have sex with men recruited online, 2013 through 2017.
    Sullivan PS; Sanchez TH; Zlotorzynska M; Chandler CJ; Sineath RC; Kahle E; Tregear S
    J Int AIDS Soc; 2020 Mar; 23(3):e25461. PubMed ID: 32153119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.